Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases

University of Zurich142 enrolled

Overview

Diagnostic accuracy of PET/magnetic resonance and PET/CT will be compared concerning primary tumor, regional nodes, metastasis (TNM) staging and therapeutic influence. Workflow scenarios will be evaluated to create imaging protocols which are time efficient and diagnostically accurate.

Study Type

OBSERVATIONAL

Enrollment

142

Conditions

Neoplasm Staging

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male and female patients from 18-90 years * Written informed consent * Patients with a proven or suspected oncological disease referred for a clinically -Indicated PET/CT with of without contrast media Exclusion Criteria: * Pregnant or breast feeding women * Non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia) * Inclusion in another clinical trial 30 days prior to inclusion * Age \< 30years * Contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia * Known allergies to contrast CT or MRI contrast media * Patients with an glomerular filtration rate of \< 60ml/min/1.73m2

Locations (1)

University Hospital Zurich, Diagnostic and Interventional Radiology

Zurich, Canton of Zurich, Switzerland

Outcomes

Primary Outcomes

Number of patients with correct TNM staging defined with PET/magnetic resonance versus PET/CT

Time frame: 12 month

Secondary Outcomes

Number of minutes needed per PET/magnetic resonance protocol compared to PET/CT

Time frame: 12 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.